• Tata Chemicals: Approved an investment of ₹515 crore to set up an IVSD manufacturing facility.

• NTPC Green: Signed an MoU with Assago Industries to supply green ammonia, CO₂, renewable power, and other utilities.

• Sundaram Finance: Revised its fund-raising limit to ₹16,000 crore from ₹13,000 crore.

• Infosys: Renewed and expanded its multi-year strategic partnership with Madison Square Garden.

• Unichem Laboratories: USFDA inspection at the Kolhapur API facility resulted in five observations.

• BPCL: Clarified that its crude oil supply agreement with Trafigura is part of normal business operations and not a trigger for recent price movement.

• eMudhra: Announced the merger of US-based AI Cyber Forge Inc. with its subsidiary, eMudhra Inc.

• BLS International: Acquired a 95% stake in MVA International, a Bahrain-based visa and passport processing company, for 1,000 BHD.

• Brightcom Group: Approved the cancellation of preferential allotments made to LGOF Global Opportunities and Connecor Investment Enterprise.

• Interarch Building Solutions: Approved the commencement of Phase II of its Andhra Pradesh plant, adding 24,000 MT capacity.

• Jash Industries: NCLT approved the merger of Shivpad Engineers with Jash Engineering.

• Tata Steel: Infused ₹5,754 crore into its overseas subsidiary, T Steel Holdings.

• Oil India: Clarified that reports on seismic studies and block acquisition are general in nature and not linked to stock price movement.

• Brigade Hotel Ventures: Signed an MoU with the Tamil Nadu government to invest ₹1,100 crore in Chennai, adding over 500 hotel keys across three properties.

• RITES: Re-signed an MoU with SAIL for locomotive leasing and maintenance services.

• Orient Green Power: Its subsidiary approved an expansion plan by entering into an EPC contract worth ₹85 crore with Renfra Energy India.

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.